Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioblastoma management in the temozolomide era: have we improved outcome?
Lwin Z, MacFadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, Menard C, Laperriere N, Mason WP. Lwin Z, et al. Among authors: mason wp. J Neurooncol. 2013 Nov;115(2):303-10. doi: 10.1007/s11060-013-1230-3. Epub 2013 Aug 25. J Neurooncol. 2013. PMID: 23979682
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.
McNamara MG, Lwin Z, Jiang H, Templeton AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N, Mason WP. McNamara MG, et al. Among authors: mason wp. J Neurooncol. 2014 Mar;117(1):147-52. doi: 10.1007/s11060-014-1366-9. Epub 2014 Jan 28. J Neurooncol. 2014. PMID: 24469854
Glioblastoma treatment in the elderly in the temozolomide therapy era.
Coate L, McNamara MG, Lwin Z, Macfadden D, Al-Zahrani A, Massey C, Menard C, Millar BA, Sahgal A, Laperriere N, Mason WP. Coate L, et al. Among authors: mason wp. Can J Neurol Sci. 2014 May;41(3):357-62. doi: 10.1017/s0317167100017303. Can J Neurol Sci. 2014. PMID: 24718821
A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study.
Mason WP, Macneil M, Kavan P, Easaw J, Macdonald D, Thiessen B, Urva S, Lwin Z, McIntosh L, Eisenhauer E. Mason WP, et al. Invest New Drugs. 2012 Dec;30(6):2344-51. doi: 10.1007/s10637-011-9775-5. Epub 2011 Dec 9. Invest New Drugs. 2012. PMID: 22160854 Clinical Trial.
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP; Trial Investigators. Perry JR, et al. Among authors: mason wp. N Engl J Med. 2017 Mar 16;376(11):1027-1037. doi: 10.1056/NEJMoa1611977. N Engl J Med. 2017. PMID: 28296618 Free article. Clinical Trial.
Radiation plus Temozolomide in Patients with Glioblastoma.
Perry JR, Laperriere N, Mason WP. Perry JR, et al. Among authors: mason wp. N Engl J Med. 2017 Jun 1;376(22):2197. doi: 10.1056/NEJMc1704726. N Engl J Med. 2017. PMID: 28564572 No abstract available.
163 results